December 9, 2016
Valneva to test its Lyme disease vaccine
Valneva said on Friday it will sent its Lyme disease vaccine candidate VLA15 to clinic. Phase I testing can begin…
Pharmaceuticals, Biotechnology and Life Sciences
Valneva said on Friday it will sent its Lyme disease vaccine candidate VLA15 to clinic. Phase I testing can begin…
Valneva has reported financial results for first nine months of 2016.
GE Healthcare and Valneva have joined forces to create cell culture medium for vaccine
Velneva’s Clostridium difficile vaccine Candidate meets Phase II trial target